Mosaic ImmunoEngineering (CPMV) Invested Capital (2024 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Invested Capital of $200000.0 for Q1 2026, little changed year-over-year from $200000.0 in Q1 2025, and little changed quarter-over-quarter from $200000.0 in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Invested Capital (2024 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Invested Capital history runs 3 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- In Q1 2026, Invested Capital changed 0.0% year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $800000.0 (up 50.92% YoY), while the FY2025 annual figure was $200000.0, changed 0.0% from the prior year.
- Invested Capital for Q1 2026 stood at $200000.0, roughly flat from $200000.0 in the prior quarter.
- The five-year high for Invested Capital was $200000.0 in Q4 2024, with the low at $56133.0 in Q2 2024.
- The 3-year median for Invested Capital is $200000.0 (2024), against an average of $166260.4.
- Peak annual rise in Invested Capital reached 256.3% in 2025, while the deepest fall reached 0.0% in 2025.
- Mosaic ImmunoEngineering's Invested Capital stood at $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- Business Quant data shows CPMV's Invested Capital at $200000.0 in Q1 2026, $200000.0 in Q4 2025, and $200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 73,950.00 |
| Jun 30, 2024 | 56,133.00 |